Designed for genetic testing in critically ill newborns and young children under 24 months in ICU. It covers multiple genetic conditions with overlapping symptoms and allows for a single test using dried blood spots for accurate diagnosis.
For metabolic and liver diseases, screening for a diverse range of disorders including intermediary metabolism, energetic processes, and cellular organelle-related conditions.
For patients suspected of metabolic disorders or complex conditions, especially in NICU/PICU settings. It offers fast results, utilises a multiomic approach, and includes enzyme activity testing and continuously updated biomarkers.
Covers the entire mitochondrial genome and can detect heteroplasmy down to 15.0%. It also tests for nuclear genes related to mitochondrial diseases, which primarily affect organs with high energy demands.
Includes mitochondrial genes. Nuclear mitochondrial genes are not included.
Suitable for patients with various glucose metabolism abnormalities and insulin-related disorders, including Prader-Willi syndrome detection. However, it does not cover disorders caused by imprinting errors or uniparental disomy, except for the genomic region 15q11, which is included in the analysis.